Synopsis
Synopsis
0
VMF
0
Canada
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (2-(4-((r)-(4-chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic Acid Dihydrochloride
2. (2-(4-((r)-p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic Acid
3. Acetic Acid, (2-(4-((r)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-
4. Acetic Acid, (2-(4-((r)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, Dihydrochloride
5. Cetirizine (r)-form Dihydrochloride
6. Levocetirizine
7. Levocetirizine Hydrochloride
8. Levocetrizine
9. Ucb-28556
10. Xusal
11. Xyzal
1. 130018-87-0
2. Xyzal
3. Xusal
4. (r)-cetirizine Dihydrochloride
5. Levocetirizine Hcl
6. Levocetirizine Dihydrochloride [usan]
7. Cetirizine (r)-form Dihydrochloride
8. Ucb-28556
9. Sod6a38aga
10. Ucb 28556
11. (2-(4-((r)-(4-chlorophenyl)phenylmethyl)piperazin-1-yl)ethoxy)acetic Acid Dihydrochloride
12. (r)-2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic Acid Dihydrochloride
13. Acetic Acid, (2-(4-((r)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, Dihydrochloride
14. Nsc-758898
15. Levocetirizine Hydrochloride (jan)
16. (-)-cetirizine Dihydrochloride
17. 2-[2-[4-[(r)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic Acid;dihydrochloride
18. 2-[2-[4-[(r)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic Acid Dihydrochloride
19. Levocetirizine (dihydrochloride)
20. Levocetirizine Hydrochloride [jan]
21. Levocetirizine 2hcl
22. Unii-sod6a38aga
23. Levocetirizine Dihcl
24. Mfcd07366507
25. Xyzal Allergy 24hr
26. Xyzal (tn)
27. Levocetirizinedihydrochloride
28. Schembl144375
29. Chembl1201190
30. Levocetirizine Hydrochloride,(s)
31. Dtxsid30926567
32. Bcp21544
33. Ac-549
34. Levocetirizine Dihydrochloride (usp)
35. S4849
36. Akos015994681
37. Ccg-269359
38. Cs-w011557
39. Hy-w010841
40. Ks-1177
41. Nsc 758898
42. [2-[4-[(r)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-acetic Acid 2hcl
43. 2-[2-[4-[(r)-(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic Acid Dihydrochloride
44. Levocetirizine Hydrochloride [mart.]
45. L0264
46. Levocetirizine Dihydrochloride [vandf]
47. Levocetirizine(r)-cetirizine (hydrochloride)
48. D08118
49. Levocetirizine Dihydrochloride [usp-rs]
50. Levocetirizine Dihydrochloride [who-dd]
51. Levocetirizine Dihydrochloride, >=98% (hplc)
52. Cetirizine (r)-form Dihydrochloride [mi]
53. 018l870
54. Levocetirizine Dihydrochloride [orange Book]
55. Levocetirizine Dihydrochloride [usp Monograph]
56. Q27289313
57. [2-[4-[(r)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-acetic Acid Dihydrochloride
Molecular Weight | 461.8 g/mol |
---|---|
Molecular Formula | C21H27Cl3N2O3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 8 |
Exact Mass | 460.108726 g/mol |
Monoisotopic Mass | 460.108726 g/mol |
Topological Polar Surface Area | 53 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 443 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 4 | |
---|---|
Drug Name | Levocetirizine dihydrochloride |
Drug Label | Levocetirizine dihydrochloride, the active component of levocetirizine dihydrochloride tablets, is an orally active H1-receptor antagonist. The chemical name is R-(+)-2-[2-[4-[(4-chlorophenyl) phenyl methyl] piperazin-1-yl] ethoxy] acetic acid dihydr... |
Active Ingredient | Levocetirizine dihydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2.5mg/5ml; 5mg |
Market Status | Prescription |
Company | Synthon Pharms; Apotex; Hetero Labs Ltd Iii; Sciegen Pharms; Taro Pharm Inds; Sun Pharma Global; Glenmark Generics; Teva Pharms; Micro Labs Ltd India; Dr Reddys Labs; L Perrigo |
2 of 4 | |
---|---|
Drug Name | Xyzal |
PubMed Health | Levocetirizine (By mouth) |
Drug Classes | Respiratory Agent |
Drug Label | Levocetirizine dihydrochloride, the active component of XYZAL tablets and oral solution, is an orally active H1receptor antagonist. The chemical name is (R)-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl] ethoxy] acetic acid dihydrochloride.... |
Active Ingredient | Levocetirizine dihydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2.5mg/5ml; 5mg |
Market Status | Prescription |
Company | Ucb |
3 of 4 | |
---|---|
Drug Name | Levocetirizine dihydrochloride |
Drug Label | Levocetirizine dihydrochloride, the active component of levocetirizine dihydrochloride tablets, is an orally active H1-receptor antagonist. The chemical name is R-(+)-2-[2-[4-[(4-chlorophenyl) phenyl methyl] piperazin-1-yl] ethoxy] acetic acid dihydr... |
Active Ingredient | Levocetirizine dihydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2.5mg/5ml; 5mg |
Market Status | Prescription |
Company | Synthon Pharms; Apotex; Hetero Labs Ltd Iii; Sciegen Pharms; Taro Pharm Inds; Sun Pharma Global; Glenmark Generics; Teva Pharms; Micro Labs Ltd India; Dr Reddys Labs; L Perrigo |
4 of 4 | |
---|---|
Drug Name | Xyzal |
PubMed Health | Levocetirizine (By mouth) |
Drug Classes | Respiratory Agent |
Drug Label | Levocetirizine dihydrochloride, the active component of XYZAL tablets and oral solution, is an orally active H1receptor antagonist. The chemical name is (R)-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl] ethoxy] acetic acid dihydrochloride.... |
Active Ingredient | Levocetirizine dihydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2.5mg/5ml; 5mg |
Market Status | Prescription |
Company | Ucb |
Histamine H1 Antagonists, Non-Sedating
A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : Complete
Rev. Date : 2022-03-09
Pay. Date : 2022-02-08
DMF Number : 22898
Submission : 2009-05-22
Status : Active
Type : II
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34731
Submission : 2020-05-12
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-10
Pay. Date : 2017-02-22
DMF Number : 21005
Submission : 2007-11-02
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22677
Submission : 2009-03-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23659
Submission : 2010-03-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-05-02
Pay. Date : 2017-04-18
DMF Number : 20173
Submission : 2007-01-17
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-12-29
Pay. Date : 2017-11-28
DMF Number : 21110
Submission : 2007-12-06
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21214
Submission : 2008-01-04
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-06-02
Pay. Date : 2017-04-27
DMF Number : 22286
Submission : 2008-12-15
Status : Active
Type : II
Levocetirizine Dihydrochloride
Certificate Number : CEP 2023-225 - Rev 00
Status : Valid
Issue Date : 2024-07-09
Type : Chemical
Substance Number : 3115
Levocetirizine Dihydrochloride
Certificate Number : CEP 2024-049 - Rev 00
Status : Valid
Issue Date : 2025-03-21
Type : Chemical
Substance Number : 3115
Levocetirizine Dihydrochloride
Certificate Number : CEP 2024-050 - Rev 00
Status : Valid
Issue Date : 2024-08-26
Type : Chemical
Substance Number : 3115
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Registration Number : 302MF10110
Registrant's Address : Flat No. 302, Bhanu Enclave, Sunder Nagar, Erragadda, Hyderabad - 500038, Telangana, ...
Initial Date of Registration : 2020-09-14
Latest Date of Registration : 2020-09-14
Registration Number : 230MF10147
Registrant's Address : 4-8-2 Nihonbashi Honcho, Chuo-ku, Tokyo
Initial Date of Registration : 2018-11-05
Latest Date of Registration : 2018-11-05
Levocetirizine Hydrochloride (for manufacturing purposes only)
Registration Number : 230MF10135
Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture
Initial Date of Registration : 2018-09-14
Latest Date of Registration : 2019-11-19
Registration Number : 230MF10149
Registrant's Address : 3697-8 Hagishima, Funamachi, Toyama City, Toyama Prefecture
Initial Date of Registration : 2018-11-07
Latest Date of Registration : 2018-11-07
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Levocetirizine Dihydrochloride USP
Date of Issue : 2024-04-03
Valid Till : 2027-01-21
Written Confirmation Number : WC-0493
Address of the Firm : Unit-IV, Plot No: 34B, 40B & 60B, J.N. Pharma City, Thanam (V), Parawada (M), An...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Levocetirizine Dihydrochloride IH
Date of Issue : 2025-05-28
Valid Till : 2028-06-25
Written Confirmation Number : WC-0035
Address of the Firm : Chemical Technical Operations, Unit -Ill, Plot No. 116,Sri Venkateswara Co-opera...
Levocetirizine Dihydrochloride IH
Date of Issue : 2022-07-06
Valid Till : 2025-06-25
Written Confirmation Number : WC-0057n
Address of the Firm : Plot No. 3109, GIDC, Industrial Estate Ankleshwar, Distt- Bharuch - 393002, Guja...
Levocetrizine Dihydrochloride IHS/IP
Date of Issue : 2022-07-05
Valid Till : 2025-09-08
Written Confirmation Number : WC-0143n
Address of the Firm : Plot No. A-42 MIDC Patalganga Khalapur, Raigad-410220, Maharashtra India
Levocetirizine Dihydrochloride USP/IH
Date of Issue : 2022-07-25
Valid Till : 2025-11-09
Written Confirmation Number : WC-0013
Address of the Firm : 174 TO 176, IDA, Bollaram, Jinnaram Mandai, Sangareddy District, Telangana State...
Levocetirizine Dihydrochloride USP/IH
Date of Issue : 2025-07-07
Valid Till : 2028-01-13
Written Confirmation Number : WC-0331
Address of the Firm : Plot No. 38, Rafaleshwar, G.I.D.C., N. H. No 8/A, At & Post. Jambudia
Levocetirizine Hydrochloride IH
Date of Issue : 2022-10-17
Valid Till : 2025-09-09
Written Confirmation Number : WC-0193
Address of the Firm : Plot No.1, Block No. 206, Moje Jolwa, Tal. Palsana, Dist-Surat, Pin-394305, Guja...
Levocetirizine Dihydrochloride IH/USP
Date of Issue : 2022-10-17
Valid Till : 2025-09-09
Written Confirmation Number : WC-0193
Address of the Firm : Plot No.1, Block No. 206, Moje Jolwa, Tal. Palsana, Dist-Surat, Pin-394305, Guja...
Levocetirizine Dihydrochloride USP
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm : Plot No. 24/2, & 25, Phase -IV, GIDC Industrial Zone, At & Post - Panoli, Dist.-...
Levocetirizine Dihydrochloride Ph. Eur
Date of Issue : 2022-11-28
Valid Till : 2025-09-08
Written Confirmation Number : WC-0072
Address of the Firm : Unit-ll, Plot No.: 25/B, Phase-lll, IDA, Jeedimetla (V), Quthbullapur (M), Medch...
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Registrant Name : Hiple Co., Ltd.
Registration Date : 2016-05-02
Registration Number : 20090720-40-C-258-15(3)
Manufacturer Name : Granules India Limited
Manufacturer Address : Plot No 8, Jawaharlal Nehru Pharma City, Tadi Village, Parawada Mandal, Vitsakhapatna...
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Registrant Name : Dongkwang Pharmaceutical Co., Ltd.
Registration Date : 2016-02-25
Registration Number : 20090720-40-C-258-15(2)
Manufacturer Name : Granules India Limited
Manufacturer Address : Plot No 8, Jawaharlal Nehru Pharma City, Tadi Village, Parawada Mandal, Vitsakhapatna...
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2009-07-20
Registration Number : 20090720-40-C-258-15
Manufacturer Name : Granules India Limited_x000D...
Manufacturer Address : Plot No 8, Jawaharlal Nehru Pharma City, Tadi Village, Parawada Mandal, Vitsakhapatna...
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2024-01-25
Registration Number : 20240125-40-C-406-23
Manufacturer Name : Glochem Industries Private L...
Manufacturer Address : Survey No.:174-176, IDA Bollaram Jinnaram Mandal, Sangareddy District, Telangana Stat...
Registrant Name : Toru Co., Ltd.
Registration Date : 2019-12-30
Registration Number : 20120113-40-C-291-19(7)
Manufacturer Name : Hunan Jiudian Pharmaceutical...
Manufacturer Address : Hunan Liuyang Bio-pharmaceutical Industrial Park, China
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2015-09-09
Registration Number : 20120113-40-C-291-19(4)
Manufacturer Name : Hunan Jiudian Pharmaeutical ...
Manufacturer Address : Hunan Liuyang Bio-Pharmaceutical Park, China
Registrant Name : RH Biopharm Co., Ltd.
Registration Date : 2021-08-27
Registration Number : 20210827-40-C-395-22
Manufacturer Name : Hunan Jiudian Hongyang Pharm...
Manufacturer Address : Tongguan Circular Economy Industrial base, WangCheng Economic and Technological Devel...
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2016-01-22
Registration Number : 20120113-40-C-291-19(6)
Manufacturer Name : Hunan Jiudian Pharmaceutical...
Manufacturer Address : HuNan Liuyang Bio-Pharmaceutical Park, China
Registrant Name : Korea UCB Pharmaceutical Co., Ltd.
Registration Date : 2020-05-13
Registration Number : 20200513-40-C-385-20
Manufacturer Name : Symed Labs Limited
Manufacturer Address : Plot No.25/B, Phase-III, IDA Jeedimetla(v), Quthbullapur(M), Medchal-Malkajgiri Distr...
Registrant Name : Sanil Pharma Co., Ltd.
Registration Date : 2024-07-25
Registration Number : 20200513-40-C-385-20(1)
Manufacturer Name : Symed Labs Limited
Manufacturer Address : Plot No.25/B, Phase-III, IDA Jeedimetla(v), Quthbullapur(M), Medchal-Malkajgiri Distr...
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 62207-009
Start Marketing Date : 2018-09-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 42765-008
Start Marketing Date : 2020-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 55111-045
Start Marketing Date : 2013-10-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 66039-837
Start Marketing Date : 2009-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 52562-300
Start Marketing Date : 2011-09-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 52562-006
Start Marketing Date : 2021-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 49574-521
Start Marketing Date : 2019-06-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 65372-1161
Start Marketing Date : 2011-09-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 62991-3149
Start Marketing Date : 2019-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
LEVOCETIRIZINE DIHYDROCHLORIDE
NDC Package Code : 66022-0108
Start Marketing Date : 2008-01-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
74
PharmaCompass offers a list of Levocetirizine Dihydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levocetirizine Dihydrochloride manufacturer or Levocetirizine Dihydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levocetirizine Dihydrochloride manufacturer or Levocetirizine Dihydrochloride supplier.
PharmaCompass also assists you with knowing the Levocetirizine Dihydrochloride API Price utilized in the formulation of products. Levocetirizine Dihydrochloride API Price is not always fixed or binding as the Levocetirizine Dihydrochloride Price is obtained through a variety of data sources. The Levocetirizine Dihydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levocetirizine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levocetirizine, including repackagers and relabelers. The FDA regulates Levocetirizine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levocetirizine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levocetirizine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levocetirizine supplier is an individual or a company that provides Levocetirizine active pharmaceutical ingredient (API) or Levocetirizine finished formulations upon request. The Levocetirizine suppliers may include Levocetirizine API manufacturers, exporters, distributors and traders.
click here to find a list of Levocetirizine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levocetirizine DMF (Drug Master File) is a document detailing the whole manufacturing process of Levocetirizine active pharmaceutical ingredient (API) in detail. Different forms of Levocetirizine DMFs exist exist since differing nations have different regulations, such as Levocetirizine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levocetirizine DMF submitted to regulatory agencies in the US is known as a USDMF. Levocetirizine USDMF includes data on Levocetirizine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levocetirizine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levocetirizine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Levocetirizine Drug Master File in Japan (Levocetirizine JDMF) empowers Levocetirizine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Levocetirizine JDMF during the approval evaluation for pharmaceutical products. At the time of Levocetirizine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Levocetirizine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levocetirizine Drug Master File in Korea (Levocetirizine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levocetirizine. The MFDS reviews the Levocetirizine KDMF as part of the drug registration process and uses the information provided in the Levocetirizine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levocetirizine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levocetirizine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levocetirizine suppliers with KDMF on PharmaCompass.
A Levocetirizine CEP of the European Pharmacopoeia monograph is often referred to as a Levocetirizine Certificate of Suitability (COS). The purpose of a Levocetirizine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Levocetirizine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Levocetirizine to their clients by showing that a Levocetirizine CEP has been issued for it. The manufacturer submits a Levocetirizine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Levocetirizine CEP holder for the record. Additionally, the data presented in the Levocetirizine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Levocetirizine DMF.
A Levocetirizine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Levocetirizine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Levocetirizine suppliers with CEP (COS) on PharmaCompass.
A Levocetirizine written confirmation (Levocetirizine WC) is an official document issued by a regulatory agency to a Levocetirizine manufacturer, verifying that the manufacturing facility of a Levocetirizine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levocetirizine APIs or Levocetirizine finished pharmaceutical products to another nation, regulatory agencies frequently require a Levocetirizine WC (written confirmation) as part of the regulatory process.
click here to find a list of Levocetirizine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levocetirizine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levocetirizine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levocetirizine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levocetirizine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levocetirizine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levocetirizine suppliers with NDC on PharmaCompass.
Levocetirizine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levocetirizine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levocetirizine GMP manufacturer or Levocetirizine GMP API supplier for your needs.
A Levocetirizine CoA (Certificate of Analysis) is a formal document that attests to Levocetirizine's compliance with Levocetirizine specifications and serves as a tool for batch-level quality control.
Levocetirizine CoA mostly includes findings from lab analyses of a specific batch. For each Levocetirizine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levocetirizine may be tested according to a variety of international standards, such as European Pharmacopoeia (Levocetirizine EP), Levocetirizine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levocetirizine USP).